Dr. Mohammed Moquitul Haque leads the Clinical Genomics division at Operifytech Pvt. Ltd., bringing over a decade of expertise in human genetics, molecular diagnostics, and translational oncology. He holds a Ph.D. in Life Sciences (Cancer Genetics) from Advanced centre for Treatment Research and Education in Cancer – Tata Memorial Centre (ACTREC-TMC) and has led high-impact teams and projects across leading genomics laboratories in India.

Dr. Haque's core expertise lies in the interpretation of somatic variants for solid tumors and hematological malignancies and germline variants for hereditary cancers, rare genetic disorders, using advanced NGS platforms. His experience spans a wide array of technologies, including Exome sequencing, Sanger sequencing, MLPA, RT-PCR. He has played pivotal roles in developing and validating molecular and NGS based assays, optimizing bioinformatics workflows, and enhancing clinical report quality across various tests in different molecular labs.

A recognized leader in oncogenomics, rare disorder genomics, molecular assays and clinical variant curation, Dr. Haque has significantly contributed to precision medicine initiatives and has record of training and mentoring scientific teams. His contributions are marked by publications and a strong commitment to integrating genomics into routine clinical care. At Operifytech Pvt. Ltd., he spearheads the clinical genomics division, advancing the challenging mission to translate genomic data into actionable insights for patient-centric diagnostics and research.